Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

424.99 -4.61 (-1.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
61 62 Next >
Moonshot Medicine: 3 Stocks to Buy to Bet on Long-Shot Drugs
The best drug stocks to buy now are shooting for the moon. These three trailblazers will land among the stars. 
Via InvestorPlace
The Best Stocks to Invest $5,000 in Right Now
Now is a great time to buy Amazon, Enterprise Products Partners, and Vertex Pharmaceuticals. 
Via The Motley Fool
$100 Invested In Vertex Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Why Editas Medicine Stock Is Soaring Today
Investors are cheering a big analyst upgrade for the gene-editing stock. 
Via The Motley Fool
Analyst Ratings for Vertex Pharmaceuticals
Via Benzinga
Crispr Therapeutics, And CRISPR Gene-Editing, Face Their Make-Or-Break Moment
The FDA is within three months of making a decision on the first-ever CRISPR-based drug. 
Via Investor's Business Daily
Exposures Product Safety
Looking Into Vertex Pharmaceuticals's Recent Short Interest
Via Benzinga
This Is What Whales Are Betting On Vertex Pharmaceuticals
Via Benzinga
Price Over Earnings Overview: Vertex Pharmaceuticals
Via Benzinga
Don’t Miss the Boom: 3 Pharma Stocks Set to Explode Higher
These pharma stocks could boom in the coming years, riding their diversified pipelines with massive addressable markets higher. 
Via InvestorPlace
Three Of Our Top Picks For Your Healthcare Portfolio
Amidst macro uncertainty, healthcare stocks should outperform. 
Via Talk Markets
Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher
With their seamless blend of promise and innovation, these biotech stocks to buy offer a strategic gateway to fortify your portfolio. 
Via InvestorPlace
Buying These 2 Remarkable Growth Stocks in Any Market Could Be a Genius Move
Great companies haven't gone anywhere. 
Via The Motley Fool
3 Magnificent Growth Stocks to Buy Right Now
If you're looking for growth, these stocks could be just the ticket. 
Via The Motley Fool
2 Healthcare Stocks That Could Make You Richer
They've beaten the market before. 
Via The Motley Fool
Is NASDAQ:VRTX suited for quality investing?
Reasonable growth and debt and a high ROIC for VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX). 
Via Chartmill
Meta Stock Leads 5 Names Showing Resilience In Market Downturn
These stocks have held up so far, but patience is key amid the correction. 
Via Investor's Business Daily
3 Unstoppable Stocks to Buy and Hold for the Next 20 Years
These stocks are great long-term picks. 
Via The Motley Fool
Where Will CRISPR Therapeutics Be in 5 Years?
The company hasn't performed well in the past five years, but things could change. 
Via The Motley Fool
2 Top Trends to Invest $500 In Right Now
Early investors in these trends may reap the rewards over time. 
Via The Motley Fool
Here's the 1 Cathie Wood Stock Most Likely to Turn $100,000 Into $1 Million Over the Next 20 Years
There's no guarantee that any stock will be a millionaire-maker. But the chances for this one look pretty good. 
Via The Motley Fool
Looking for Growth? These Companies' Revenue May Skyrocket
Catalysts on the horizon could drive gains in these top stocks. 
Via The Motley Fool
If You Invested $30,000 in CRISPR Therapeutics in 2016, This Is How Much You Would Have Today
The returns are impressive, but will they continue to be so? 
Via The Motley Fool
Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
Via Benzinga
Vertex Receives CHMP Positive Opinion for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor for Children With Cystic Fibrosis Ages 2 Through 5
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions. 
Via Investor's Business Daily
Exposures Product Safety
3 Top Healthcare Stocks Defying the Bear Market
Revenue at all three companies improved last quarter, and their share prices have followed suit. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Vertex Researchers Awarded 2024 Breakthrough Prize in Life Sciences
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Better Bull Market Buy: CRISPR vs. Medtronic Stock
Investors may look for growth stocks ahead of the next bull market. 
Via The Motley Fool
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
61 62 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback